Quoin Pharmaceuticals Ltd (NASDAQ:QNRX)
| 1.29 Delayed Data As of Jan 26 |  -0.09 / -6.52%Today’s Change | 1.13 Today|||52-Week Range 35.52 | -29.12% Year-to-Date |
Latest QNRX News | Press Releases
No recent news for Quoin Pharmaceuticals Ltd.
Today’s Trading
| Previous close | 1.38 |
| Today’s open | 1.28 |
| Day’s range | 1.32 - 1.38 |
| Volume | 6,183 |
| Average volume (3 months) | 1,519,888 |
| Market cap | $11.1M |
Data as of 3:47pm ET, 01/26/2022
Growth & Valuation
| Earnings growth (last year) | -34.78% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | -- |
| Price/Sales | -- |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PHIOPhio Pharmaceuticals... | -0.02 | -2.14% |
| BLCMBellicum Pharmaceuti... | 0.00 | 0.00% |
| SNESSenestech Inc | +0.05 | +5.27% |
| PALIPalisade Bio Inc | 0.00 | 0.00% |
Data as of 3:57pm ET, 01/26/2022
Financials
| Next reporting date | March 21, 2022 |
| EPS forecast (this quarter) | -$0.84 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$2.1M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Ashburn, Virginia |
Forecasts
